FIBROGEN INC Annual Income Tax Expense (Benefit) in USD from 2013 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Fibrogen Inc quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2013 to 2024.
  • Fibrogen Inc Income Tax Expense (Benefit) for the quarter ending December 31, 2024 was -$52K, a 70.3% increase year-over-year.
  • Fibrogen Inc Income Tax Expense (Benefit) for the twelve months ending December 31, 2024 was -$269K, a 6.75% decline year-over-year.
  • Fibrogen Inc annual Income Tax Expense (Benefit) for 2024 was -$269K, a 6.75% decline from 2023.
  • Fibrogen Inc annual Income Tax Expense (Benefit) for 2023 was -$252K, a 170% decline from 2022.
  • Fibrogen Inc annual Income Tax Expense (Benefit) for 2022 was $358K, a 3.17% increase from 2021.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$269K -$17K -6.75% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-17
2023 -$252K -$610K -170% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-17
2022 $358K +$11K +3.17% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-26
2021 $347K -$13K -3.61% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-26
2020 $360K +$32K +9.76% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-27
2019 $328K +$24K +7.9% Jan 1, 2019 Dec 31, 2019 10-K/A 2022-03-04
2018 $304K -$17K -5.3% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-01
2017 $321K +$392K Jan 1, 2017 Dec 31, 2017 10-K 2020-03-02
2016 -$71K -$313K -129% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-27
2015 $242K +$242K Jan 1, 2015 Dec 31, 2015 10-K 2018-02-27
2014 $0 $0 Jan 1, 2014 Dec 31, 2014 10-K 2017-03-01
2013 $0 Jan 1, 2013 Dec 31, 2013 10-K 2016-02-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.